Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Genpro Appoints Steve Herbert as the Chief Commercial Officer of Genpro Research

Genpro Research, a Waltham, MA based next-generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry has announced the appointment of Steve Herbert as the Chief Commercial Officer of the company

Genpro Research announced the appointment of Steve Herbert as Chief Commercial Officer of Genpro Research Inc., leading the commercial, BD and sales strategy. He will be based out of company’s Boston office.

Mr. Herbert brings over 20 years of commercial leadership and expertise in the US & European Clinical Research & Pharmaceutical software markets as well as an in-depth knowledge of the pharmaceutical industry.

Steve was raised in London, graduated in Biology (Hons.) from York University, UK.

Recommended AI News: Mphasis Is a Leading Machine Learning (ML) Solutions Partner in AWS Marketplace

Related Posts
1 of 40,477

”Steve’s appointment demonstrates the continued commitment of Genpro Research to expanding the scope and reach of our products and services to our global customers,” said Anoop Ambika, Chief Executive Officer of Genpro Research. “Over the last 24 months, Genpro Research has been rapidly expanding and increasing its footprint in India and US. Steve’s wealth of experience in scaling small and medium enterprises in the US & European markets will greatly enhance our position internationally and provide the expertise and leadership that we need to serve our clients more effectively worldwide. Steve is a strong addition to the executive management team and an asset to our global strategy.”

Recommended AI News: SentinelOne Announces Automated Application Control for Cloud and Container Security

Before joining Genpro, Steve led Cytel’s business development from a small research-based venture to its sale to New Mountain Capital as a leading statistical clinical software & service company. A specialist in transformational growth of smaller enterprises, as an investor, consultant, executive and board member, Steve has managed the commercial operations for Accelrys (Acquired by Dassault), Wavemark (Acquired by Cardinal Health), OmniViz (Acquired by Instem) and several other start-ups. His career bridges life sciences and technology – two professional interests and, not coincidentally, two huge driving forces in today’s society.

Steve is a pianist (jazz, pop and classical) and owns a music recording studio where he mentors young, aspiring musicians. He loves kayaking, hiking, and skiing. He has three grown boys and lives with his wife, Ursula, in Concord, MA.

Recommended AI News: VMray Signs Partnership With Sababa Security to Expand Into Italian Cybersecurity Market

Comments are closed, but trackbacks and pingbacks are open.